Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World Data – Annals of Internal Medicine Commentaries: Apixaban shows superior effectiveness, safety compared to rivaroxaban – ACP Internist Recurrent VTE and Bleeding With Apixaban vs. Rivaroxaban – American College of Cardiology  

The post Retrospective cohort study: In patients with venous thromboembolism (VTE), treatment with apixaban was associated with lower rates for recurrent VTE and bleeding compared to rivaroxaban. appeared first on Links Medicus.